Post

The FDA just approved daraxonrasib, a breakthrough drug for advanced pancreatic cancer that doubles survival time. This is huge: pancreatic cancer was once thought untreatable. The researchers received a standing ovation when they presented the trial results, unheard of at scientific conferences.

lakelady

@lakelady.bsky.social

26 Aug

I just had a friend die of this six weeks after diagnosis. Doubling survival time would have given her 12 weeks. Sorry but I don't find that worth celebrating. How about better diagnostic tools so it can be caught much earlier in the process. That I would celebrate.

ave

@ave.zone

sorry about your friend. many in this thread are sharing experiences of it being caught earlier than her. we don't have to and should not focus science in one direction, some may focus on evaluating approaches for fighting cancer while others evaluate approaches to do early diagnosis.

26/8/26, 8:49 pm0 reposts6 likes

No replies yet.